PEMETREXED DITROMETAMINA DR REDDY'S 500mg powder for concentrate infusion solution medication leaflet

L01BA04 pemetrexeda • Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues

Pemetrexed is a chemotherapy agent used in the treatment of lung cancer and malignant pleural mesothelioma. It works by inhibiting enzymes involved in DNA and RNA synthesis, thereby preventing tumor cell growth.

The medication is administered intravenously, as directed by a doctor, usually once every three weeks. It is important for patients to follow the treatment regimen and take folic acid and vitamin B12 supplements to reduce the risk of side effects.

Patients should be aware of potential side effects, such as fatigue, nausea, or decreased blood cell counts. It is important to inform the doctor of any unusual symptoms.

Common side effects include fatigue, nausea, and anemia. In rare cases, severe reactions such as hematologic toxicity or allergic reactions may occur. Patients should be informed of these risks before use.

General data about PEMETREXED DITROMETAMINA DR REDDY'S 500mg

Substance: pemetrexeda

Date of last drug list: 01-06-2025

Commercial code: W64024001

Concentration: 500mg

Pharmaceutical form: powder for concentrate infusion solution

Quantity: 1

Product type: generic

Price: 3094.14 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BETAPHARM ARZNEIMITTEL GMBH - GERMANIA

Holder: DR. REDDY'S LABORATORIES ROMANIA S.R.L. - ROMANIA

Number: 13960/2021/01

Shelf life: 2 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for pemetrexeda

1000mg, 100mg, 10mg/ml, 25mg/ml, 500mg

Other substances similar to pemetrexeda

Compensation lists for PEMETREXED DITROMETAMINA DR REDDY'S 500mg DR. REDDY'S

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

3094.14 RON

923.52 RON

2170.62 RON